Watt provides lead counsel services in mergers and acquisitions of public and private companies, and in handling private equity and venture capital-related financings involved in business formation and development. He provides corporate governance and securities guidance to public and private companies in the financial services, information technology, health care, biotechnology and nanotechnology sectors. He has served as lead counsel in acquisitions and dispositions of publicly owned health care companies, as well as in private transactions involving health care providers, including skilled nursing facilities, transitional hospitals, hospice and home health care agencies, institutional pharmacies and outpatient and rehabilitation therapy centers.

In the life sciences industry, Watt’s practice has included representation of emerging technology companies as well as institutional private equity funding sources in fields such as cancer, osteoporosis and infectious disease diagnostics and therapeutics.

Watt also has represented issuers and broker-dealers in numerous private placements and initial public and secondary offerings of securities in many other industries, including medical technology, mobile software, power electronics, other manufacturing industries and banking, specialty insurance and related financial fields.